secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001213900-25-059738
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics raises $1.85M via Series D preferred stock; adds new institutional investors
--------------------------------------------------------------------------------

- Closed additional closing of 2,315 shares of Series D convertible preferred stock for gross proceeds of ~$1,852,000.
- Entered into Amendment No. 1 to the Securities Purchase Agreement adding new institutional investors as buyers.
- New investors join through joinder agreements, becoming parties to the existing Securities Purchase Agreement.
- The Series D preferred stock is convertible into shares of CERO common stock; offering exempt under Rule 506/Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025059738/0001213900-25-059738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025059738/ea0247627-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-059738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer